| 801058 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na+]c/ROS-pathway in human endothelial cells |
2022-02-01 |
10.1016/j.biopha.2021.112515 |
Uthman Laween, Li Xiaoling, Baartscheer Antonius, Schumacher Cees A., Baumgart Patricia, Hermanides Jeroen, Preckel Benedikt, Hollmann Markus W., Coronel Ruben, Zuurbier Coert J., Weber Nina C. |
| 801057 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges |
2022-02-01 |
10.1016/j.biopha.2021.112488 |
Pal Mintu, Muinao Thingreila, Boruah Hari Prasanna Deka, Mahindroo Neeraj |
| 801056 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Therapeutic potential of CAR T cell in malignancies: A scoping review |
2022-02-01 |
10.1016/j.biopha.2021.112512 |
Mehrabadi Ali Zarezadeh, Ranjbar Reza, Farzanehpour Mahdieh, Shahriary Alireza, Dorostkar Ruhollah, Hamidinejad Mohammad Ali, Ghaleh Hadi Esmaeili Gouvarchin |
| 801055 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
6-gingerol ameliorates metabolic disorders by inhibiting hypertrophy and hyperplasia of adipocytes in high-fat-diet induced obese mice |
2022-02-01 |
10.1016/j.biopha.2021.112491 |
Cheng Zhe, Xiong Xinyu, Zhou Yi, Wu Fan, Shao Qingqing, Dong Ruolan, Liu Qiong, Li Lingli, Chen Guang |
| 801054 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Clinical application and pharmacological mechanism of Wuling powder in the treatment of ascites: A systematic review and network pharmacological analysis |
2022-02-01 |
10.1016/j.biopha.2021.112506 |
Mou Yue, Wang XueZhen, Wang Tong, Wang Yuan, Wang HuaXin, Zhao HaiJun, Chen Qian, Xia Lei, Zhang YaNan |
| 801053 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Rhubarb hydroxyanthraquinones act as antiobesity agents to inhibit adipogenesis and enhance lipolysis |
2022-02-01 |
10.1016/j.biopha.2021.112497 |
Fang Jia-You, Huang Tse-Hung, Chen Wei-Jhang, Aljuffali Ibrahim A., Hsu Ching-Yun |
| 801052 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence |
2022-02-01 |
10.1016/j.biopha.2021.112505 |
Scuteri D., Rombolà L., Hamamura K., Sakurada T., Watanabe C., Sakurada S., Guida F., Boccella S., Maione S., Gallo Afflitto G., Nucci C., Tonin P., Bagetta G., Corasaniti M.T. |
| 801051 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Impact of anti-PEG antibody affinity on accelerated blood clearance of pegylated epoetin beta in mice |
2022-02-01 |
10.1016/j.biopha.2021.112502 |
Chang Tien-Ching, Chen Bing-Mae, Wu Jer-Yuan, Cheng Tian-Lu, Roffler Steve |
| 801050 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies |
2022-02-01 |
10.1016/j.biopha.2021.112507 |
Ahmed Md. Nasir, Jahan Rownak, Nissapatorn Veeranoot, Wilairatana Polrat, Rahmatullah Mohammed |
| 801049 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Cyanidin-3-rutinoside stimulated insulin secretion through activation of L-type voltage-dependent Ca2+ channels and the PLC-IP3 pathway in pancreatic β-cells |
2022-02-01 |
10.1016/j.biopha.2021.112494 |
Kongthitilerd Phutthida, Thilavech Thavaree, Marnpae Marisa, Rong Weiqiong, Yao Shaomian, Adisakwattana Sirichai, Cheng Henrique, Sauntawee Tanyawan |
